Heterogeneous dose-escalated prostate stereotactic body radiation therapy for all risk prostate cancer: An institutional phase 2 study

Category Primary study
JournalInternational Journal of Radiation Oncology
Year 2016
This article has no abstract
Epistemonikos ID: 0e4e4d2fbc09c4067e9f2f639ecda7e996a16659
First added on: Feb 08, 2025